Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate in neoadjuvant treatment of resectable osteosarcoma: A prospective, single‐arm, exploratory phase II trial.
Saved in:
| Title: | Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate in neoadjuvant treatment of resectable osteosarcoma: A prospective, single‐arm, exploratory phase II trial. |
|---|---|
| Authors: | Tang, Qinglian1,2 (AUTHOR), Zhang, Xinke2,3 (AUTHOR), Zhu, Xiaojun1,2 (AUTHOR), Xu, Huaiyuan1,2 (AUTHOR), Song, Guohui1,2 (AUTHOR), Lu, Jinchang1,2 (AUTHOR), Wu, Hao1,2 (AUTHOR), Deng, Chuangzhong1,2 (AUTHOR), Ai, Fei2,4 (AUTHOR), Zhang, Yingchun2,3 (AUTHOR) zhangyingch@sysucc.org.cn, Wang, Jin1,2 (AUTHOR) wangjinbs@sysucc.org.cn |
| Source: | Cancer Medicine. Sep2024, Vol. 13 Issue 18, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 180149806 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate in neoadjuvant treatment of resectable osteosarcoma: A prospective, single‐arm, exploratory phase II trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Tang%2C+Qinglian%22">Tang, Qinglian</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Xinke%22">Zhang, Xinke</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhu%2C+Xiaojun%22">Zhu, Xiaojun</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Huaiyuan%22">Xu, Huaiyuan</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Song%2C+Guohui%22">Song, Guohui</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lu%2C+Jinchang%22">Lu, Jinchang</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Hao%22">Wu, Hao</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Deng%2C+Chuangzhong%22">Deng, Chuangzhong</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ai%2C+Fei%22">Ai, Fei</searchLink><relatesTo>2,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Yingchun%22">Zhang, Yingchun</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<i> zhangyingch@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Wang%2C+Jin%22">Wang, Jin</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> wangjinbs@sysucc.org.cn</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+Medicine%22">Cancer Medicine</searchLink>. Sep2024, Vol. 13 Issue 18, p1-8. 8p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=180149806 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cam4.70206 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 8 StartPage: 1 Titles: – TitleFull: Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate in neoadjuvant treatment of resectable osteosarcoma: A prospective, single‐arm, exploratory phase II trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tang, Qinglian – PersonEntity: Name: NameFull: Zhang, Xinke – PersonEntity: Name: NameFull: Zhu, Xiaojun – PersonEntity: Name: NameFull: Xu, Huaiyuan – PersonEntity: Name: NameFull: Song, Guohui – PersonEntity: Name: NameFull: Lu, Jinchang – PersonEntity: Name: NameFull: Wu, Hao – PersonEntity: Name: NameFull: Deng, Chuangzhong – PersonEntity: Name: NameFull: Ai, Fei – PersonEntity: Name: NameFull: Zhang, Yingchun – PersonEntity: Name: NameFull: Wang, Jin IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 09 Text: Sep2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 20457634 Numbering: – Type: volume Value: 13 – Type: issue Value: 18 Titles: – TitleFull: Cancer Medicine Type: main |
| ResultId | 1 |